Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Vaccination | Research

Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study

Authors: Andrew Kimera, Lynn Atuyambe, Huzaifa Mutyaba, Claire Nantongo, Agnes Namagembe, Anna Maria Nalumansi, Andrew Basenero, Prisca Auma, Nelson Mukiza, Joan Mutyoba

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Hepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention. A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vaccination. This study aims to determine the uptake and completion of HBV vaccination and associated factors among residents of Gulu, Uganda.

Methods

A mixed methods cross-sectional study was conducted in Gulu, Northern Uganda, among 434 adult residents. A pretested questionnaire was used to collect data on socio-demographics, perceptions, and knowledge of HBV vaccination. Modified Poisson regression analysis was used in STATA 14 software to obtain prevalence ratios for the association between the independent and dependent variables. For qualitative data, 9 key informant interviews were conducted and thematic analysis was done using Quirkos software.

Results

Out of the 434 respondents, 41.9% had received at least one dose of the hepatitis B vaccine, 32.5% had received at least 2 doses, and only 20% had completed all 3 doses, with an overall completion rate of 47.8% for participants who had been initiated on the vaccine. Gender, residence, risk perception of Hepatitis B infection, perceived safety of the vaccine, and awareness of mass vaccination were associated with uptake of Hepatitis B vaccination. Residence, knowledge, and perception of being at risk of acquiring Hepatitis B were associated with completion. Qualitative results revealed that the levels of uptake and completion could have been affected by access to vaccination sites; inadequate knowledge about the disease; myths about the vaccine and inadequate community engagement.

Conclusion

Low Hepatitis B vaccine uptake and completion rates were observed in Gulu. To enhance vaccination coverage, future initiatives should prioritize awareness, education, and dispelling of vaccination myths. Additionally, increased government investment in training health workers can serve as a valuable strategy to improve information dissemination and awareness among the population.
Literature
1.
go back to reference Razavi-Shearer D, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Volume 3. The lancet Gastroenterology & hepatology; 2018. pp. 383–403. 6. Razavi-Shearer D, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Volume 3. The lancet Gastroenterology & hepatology; 2018. pp. 383–403. 6.
2.
go back to reference Spearman CW, et al. Hepatitis B in sub-saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900–9.CrossRefPubMed Spearman CW, et al. Hepatitis B in sub-saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2(12):900–9.CrossRefPubMed
3.
go back to reference Organization WH. Global hepatitis report 2017: executive summary. World Health Organization; 2017. Organization WH. Global hepatitis report 2017: executive summary. World Health Organization; 2017.
4.
go back to reference Ssekamatte T, et al. Distribution of Hepatitis B prevention services in Wakiso District, Central Uganda. PLOS Global Public Health. 2023;3(9):e0000478.CrossRefPubMedPubMedCentral Ssekamatte T, et al. Distribution of Hepatitis B prevention services in Wakiso District, Central Uganda. PLOS Global Public Health. 2023;3(9):e0000478.CrossRefPubMedPubMedCentral
5.
go back to reference Bwogi J et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci, 2009. 9(2). Bwogi J et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci, 2009. 9(2).
6.
go back to reference Meenakshi, Dalal. Uganda elevates health for all with free hepatitis testing, treatment and vaccines. WHO Africa region; 2023. p. 72. Meenakshi, Dalal. Uganda elevates health for all with free hepatitis testing, treatment and vaccines. WHO Africa region; 2023. p. 72.
7.
go back to reference Stanaway JD, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of Disease Study 2013. Lancet. 2016;388(10049):1081–8.CrossRefPubMedPubMedCentral Stanaway JD, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of Disease Study 2013. Lancet. 2016;388(10049):1081–8.CrossRefPubMedPubMedCentral
8.
go back to reference Organization WH. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus, in Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. 2021. Organization WH. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus, in Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. 2021.
9.
go back to reference T MoH. Annual Health Sector Performance Report. 2016. T MoH. Annual Health Sector Performance Report. 2016.
10.
go back to reference Uganda Moh. World hepatitis day 2018: Report 2016 Uganda Population-based HIV Impact Assessment (UPHIA) Survey: press statement on the progress of implementation of hepatitis b vaccination program in Uganda Hon, 2018. Uganda Moh. World hepatitis day 2018: Report 2016 Uganda Population-based HIV Impact Assessment (UPHIA) Survey: press statement on the progress of implementation of hepatitis b vaccination program in Uganda Hon, 2018.
11.
go back to reference Commission UA. Uganda population based HIV impact assessment. Volume UAC. Uganda: Kampala; 2017. pp. 62–5. Commission UA. Uganda population based HIV impact assessment. Volume UAC. Uganda: Kampala; 2017. pp. 62–5.
12.
go back to reference Odele S. Determinants Of Hepatitis B Vaccine Uptake Among Adults In Soroti Municipality, Soroti District 2017. Odele S. Determinants Of Hepatitis B Vaccine Uptake Among Adults In Soroti Municipality, Soroti District 2017.
13.
go back to reference Baruch Y. Response rate in academic studies-A comparative analysis. Hum Relat. 1999;52(4):421–38.CrossRef Baruch Y. Response rate in academic studies-A comparative analysis. Hum Relat. 1999;52(4):421–38.CrossRef
14.
go back to reference UDHS, Uganda Demographic and Health Survey 2016: Key indicators Report. 2016, Uganda Bureau of Statistcs (UBOS), and ICF Rockville, Maryland, USA: Kampala, Uganda. UDHS, Uganda Demographic and Health Survey 2016: Key indicators Report. 2016, Uganda Bureau of Statistcs (UBOS), and ICF Rockville, Maryland, USA: Kampala, Uganda.
15.
go back to reference Jones CJ, Smith H, Llewellyn C. Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review. Health Psychol Rev. 2014;8(3):253–69.CrossRefPubMed Jones CJ, Smith H, Llewellyn C. Evaluating the effectiveness of health belief model interventions in improving adherence: a systematic review. Health Psychol Rev. 2014;8(3):253–69.CrossRefPubMed
16.
go back to reference Omotowo I, et al. Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria. Volume 18. BMC infectious diseases; 2018. pp. 1–9. 1. Omotowo I, et al. Uptake of hepatitis B vaccination and its determinants among health care workers in a tertiary health facility in Enugu, South-East, Nigeria. Volume 18. BMC infectious diseases; 2018. pp. 1–9. 1.
17.
go back to reference Feleke BE. Low coverage of hepatitis B vaccine and determinants among health professionals working in Amhara regional state hospitals, Ethiopia. J Public Health Afr, 2016. 7(2). Feleke BE. Low coverage of hepatitis B vaccine and determinants among health professionals working in Amhara regional state hospitals, Ethiopia. J Public Health Afr, 2016. 7(2).
18.
go back to reference Osei E, Niyilapah J, Kofi Amenuvegbe G. Hepatitis B knowledge, testing, and vaccination history among undergraduate public health students in Ghana BioMed research international, 2019. 2019. Osei E, Niyilapah J, Kofi Amenuvegbe G. Hepatitis B knowledge, testing, and vaccination history among undergraduate public health students in Ghana BioMed research international, 2019. 2019.
19.
go back to reference Taylor JE, et al. Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study. BMC Infect Dis. 2019;19:1–9.CrossRef Taylor JE, et al. Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study. BMC Infect Dis. 2019;19:1–9.CrossRef
20.
21.
go back to reference Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health. 2019;19(1):1–9.CrossRef Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health. 2019;19(1):1–9.CrossRef
22.
go back to reference Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ open. 2017;7(5):e015845.CrossRefPubMedPubMedCentral Ochu CL, Beynon CM. Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey. BMJ open. 2017;7(5):e015845.CrossRefPubMedPubMedCentral
23.
go back to reference Chingle M, et al. Risk perception of hepatitis B infection and uptake of hepatitis B vaccine among students of tertiary institution in Jos. Ann Afr Med. 2017;16(2):59.CrossRefPubMedPubMedCentral Chingle M, et al. Risk perception of hepatitis B infection and uptake of hepatitis B vaccine among students of tertiary institution in Jos. Ann Afr Med. 2017;16(2):59.CrossRefPubMedPubMedCentral
24.
go back to reference Meriki HD, et al. Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon. PLoS ONE. 2018;13(7):e0200157.CrossRefPubMedPubMedCentral Meriki HD, et al. Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon. PLoS ONE. 2018;13(7):e0200157.CrossRefPubMedPubMedCentral
25.
go back to reference Aroke D et al. Awareness and vaccine coverage of hepatitis B among Cameroonian medical students BioMed research international, 2018. 2018. Aroke D et al. Awareness and vaccine coverage of hepatitis B among Cameroonian medical students BioMed research international, 2018. 2018.
26.
go back to reference KENYA HI. Leah Jepkios Bett (HND). Kenyatta University; 2014. KENYA HI. Leah Jepkios Bett (HND). Kenyatta University; 2014.
Metadata
Title
Prevalence and factors associated with hepatitis b vaccination uptake and completion among communities targeted for mass vaccination in gulu: a cross-sectional study
Authors
Andrew Kimera
Lynn Atuyambe
Huzaifa Mutyaba
Claire Nantongo
Agnes Namagembe
Anna Maria Nalumansi
Andrew Basenero
Prisca Auma
Nelson Mukiza
Joan Mutyoba
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18330-2

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue